Business Description
Harm Reduction Group
ISIN : SE0006261038
Compare
Compare
Traded in other countries / regions
NOHARM.Sweden2SL.Germany IPO Date
2021-05-05Description
Harm Reduction Group operates in the non-smoking segment. The product range includes snus and e-cigarettes among others. It sells its products via physical stores, online stores and wholesale departments around the Nordic region.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | -1.25 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.55 | |||||
| Beneish M-Score | -3.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.16 | |||||
| 9-Day RSI | 46.11 | |||||
| 14-Day RSI | 46.96 | |||||
| 6-1 Month Momentum % | -38.03 | |||||
| 12-1 Month Momentum % | 2.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.41 | |||||
| Quick Ratio | 0.54 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 201.49 | |||||
| Days Sales Outstanding | 22.64 | |||||
| Days Payable | 136.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -217 | |||||
| Shareholder Yield % | 12.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.47 | |||||
| Operating Margin % | -21.55 | |||||
| Net Margin % | -24.76 | |||||
| FCF Margin % | -2.14 | |||||
| ROE % | -83.94 | |||||
| ROA % | -27.06 | |||||
| ROIC % | -33.24 | |||||
| ROC (Joel Greenblatt) % | -667.88 | |||||
| ROCE % | -45.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.12 | |||||
| PB Ratio | 0.39 | |||||
| EV-to-EBIT | -1.39 | |||||
| EV-to-EBITDA | -3 | |||||
| EV-to-Revenue | 0.27 | |||||
| EV-to-FCF | -12.13 | |||||
| Earnings Yield (Greenblatt) % | -72.04 | |||||
| FCF Yield % | -12.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harm Reduction Group Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 14.221 | ||
| EPS (TTM) (€) | -0.013 | ||
| Beta | 5.67 | ||
| Volatility % | 3417.5 | ||
| 14-Day RSI | 46.96 | ||
| 14-Day ATR (€) | 0.001635 | ||
| 20-Day SMA (€) | 0.00706 | ||
| 12-1 Month Momentum % | 2.33 | ||
| 52-Week Range (€) | 0.0002 - 0.0258 | ||
| Shares Outstanding (Mil) | 413.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harm Reduction Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harm Reduction Group Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harm Reduction Group Frequently Asked Questions
What is Harm Reduction Group(FRA:2SL)'s stock price today?
The current price of FRA:2SL is €0.01. The 52 week high of FRA:2SL is €0.03 and 52 week low is €0.00.
When is next earnings date of Harm Reduction Group(FRA:2SL)?
The next earnings date of Harm Reduction Group(FRA:2SL) is 2024-11-28.
Does Harm Reduction Group(FRA:2SL) pay dividends? If so, how much?
Harm Reduction Group(FRA:2SL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers